The pharmaceutical industry is downsizing in Europe, including the UK, because of poor returns on investment. With ageing societies and diseases of modern living, many more patients are in desperate need of many more new medicines. To this end, several scientists in Oxford are working together to create a new ecosystem for drug discovery: one which pools the considerable strengths in industry, with the resources and expertise of academia, patient organisations and regulatory agencies, in an “open” way. Prof Chas Bountra of the Nuffield Department of Medicine discusses this “pre-competitive effort” which is unrivalled by any other academic institute.
Venue: Medical Sciences Teaching Centre, South Parks Road.
Please book your place online